Stockchase Opinions

Jim Cramer - Mad Money Clorox Company CLX-N COMMENT Apr 29, 2022

They report Monday. They've had some awful quarters, so they only need to report a decent quarter to push prices rise. They need to do something with their supplements business, which is lousy.
$143.470

Stock price when the opinion was issued

misc consumer products
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

You might be interested:

WAIT
Wait for the next quarterly report. It pays a divided of 2.9%, so wait till it yields 3.3% or 3.4%. The whole industry can't find any footing.
COMMENT
It reports Monday. They may not pass their rising costs onto consumers. Maybe. He hopes for a good report, but is bracing himself for a bad one.
premium

This is a Panic-proof Portfolio opinion which is available only for Premium members

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

PAST TOP PICK
(A Top Pick Feb 09/21, Down 2.9%)Stockchase Research Editor: Michael O'Reilly To ensure progressing capital returns of our PAST TOP PICK with CLX, we recommend trailing the stop (from $150) to $165.
premium

This is a Panic-proof Portfolio opinion which is available only for Premium members

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

PAST TOP PICK
(A Top Pick Feb 09/21, Down 12.1%)Stockchase Research Editor: Michael O'Reilly Our PAST TOP PICK with CLX has triggered its stop at $165. To remain disciplined, we recommend covering the position at this time.
PAST TOP PICK
(A Top Pick Mar 08/21, Down 26%) Doesn't own stock anymore even though has recommended it to investors. Simple and straight forward product that everyone uses. Could not justify investment.
BUY
They reported a mixed quarter on Monday. Rampant cost inflation is eating alive consumer product companies which should be thriving at this stage of the cycle. Clorox has been an awful performer and many have been shorting this. They reported declining gross margins and they shaved 20 cents off their full-year earnings forecast, but they were better than expected in the previous quarter. CLorox reported a 39-cent earnings beat and announced another round of price increases for July which should help margin compression. The stock has recovered from Monday's losses and then some. The company has room to run, especially if the Fed can kill inflation.
WATCH
Nvidia is trading at the same forward PE as Clorox. It's worth looking at these quality growth names with real earnings and cash flows, because inflation will peak and the market will re-rate what the Fed will do. Investors will position themselves in such names in the second half of this year.
BUY
It had a mediocre quarter, but shares didn't decline. This means CLX is closer to a bottom, so you should be owning this.
DON'T BUY

Still really expensive at over 30x earnings for a consumer product. Not fantastic growth. Relatively weak balance sheet, lots of debt. Fairly well managed. Cost-cutting efforts can only go so far. Be careful.